Carl Zeiss Meditec AG (FRA:AFXA)
Germany · Delayed Price · Currency is EUR 27.20
-0.80 (-2.86%)
At close: Jan 30, 2026
Carl Zeiss Meditec AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | 141.21 | 178.73 | 290.4 | 293.91 | 236.28 |
Depreciation & Amortization | 75.89 | 64.03 | 45.12 | 40.31 | 37.31 |
Other Amortization | 50.49 | 68.74 | 28.94 | 29.46 | 24.27 |
Loss (Gain) From Sale of Assets | - | - | - | 0.26 | -1.01 |
Loss (Gain) on Equity Investments | -0.03 | 3.02 | 0.89 | - | - |
Other Operating Activities | -21.03 | -82.3 | 11.39 | -66.23 | 14.16 |
Change in Accounts Receivable | -106.48 | 21.62 | -21.18 | -74.37 | -62.1 |
Change in Inventory | 26.6 | 24.38 | -152.6 | -74.63 | 0.02 |
Change in Accounts Payable | 15.27 | -63.3 | 47.1 | 33.73 | 52.69 |
Change in Other Net Operating Assets | 27.95 | 32.41 | 0.81 | 5.76 | 61.04 |
Operating Cash Flow | 209.86 | 247.32 | 250.86 | 188.2 | 362.66 |
Operating Cash Flow Growth | -15.15% | -1.41% | 33.30% | -48.11% | 103.14% |
Capital Expenditures | -39.39 | -86.81 | -65.65 | -42.8 | -30.12 |
Sale of Property, Plant & Equipment | 13.69 | 0.07 | 0.36 | 0.22 | 4.83 |
Cash Acquisitions | -2.47 | -1,006 | -10.66 | -61.29 | - |
Sale (Purchase) of Intangibles | -37.2 | -65.39 | -48.21 | -39.17 | -35.98 |
Investment in Securities | -12.37 | -3.9 | -19.17 | - | -13.93 |
Other Investing Activities | -13.28 | 750.02 | 32.36 | 50.16 | - |
Investing Cash Flow | -91.03 | -412.31 | -110.98 | -92.89 | -75.2 |
Short-Term Debt Issued | 0.07 | 0.21 | - | - | 0.42 |
Long-Term Debt Issued | - | 400 | - | - | 3.98 |
Total Debt Issued | 0.07 | 400.21 | - | - | 4.4 |
Short-Term Debt Repaid | - | - | -0.01 | -0.6 | - |
Long-Term Debt Repaid | -23.37 | -23.3 | -22.99 | -21.36 | -17.73 |
Total Debt Repaid | -23.37 | -23.3 | -23 | -21.96 | -17.73 |
Net Debt Issued (Repaid) | -23.3 | 376.9 | -23 | -21.96 | -13.33 |
Repurchase of Common Stock | - | -150.08 | - | - | - |
Common Dividends Paid | -52.52 | -98.2 | -98.39 | -80.5 | -44.72 |
Other Financing Activities | -33.01 | 47.63 | -13.71 | 8.21 | -227.84 |
Financing Cash Flow | -108.83 | 176.25 | -135.09 | -94.24 | -285.89 |
Foreign Exchange Rate Adjustments | -3.02 | -1.58 | -1.92 | -0.78 | -0.34 |
Net Cash Flow | 6.98 | 9.68 | 2.87 | 0.29 | 1.24 |
Free Cash Flow | 170.46 | 160.51 | 185.21 | 145.4 | 332.54 |
Free Cash Flow Growth | 6.21% | -13.34% | 27.38% | -56.28% | 122.88% |
Free Cash Flow Margin | 7.65% | 7.77% | 8.87% | 7.64% | 20.19% |
Free Cash Flow Per Share | 1.95 | 1.81 | 2.07 | 1.63 | 3.72 |
Cash Interest Paid | 21.51 | 12.28 | 3.95 | 1.52 | 1.63 |
Cash Income Tax Paid | 76.93 | 116.58 | 107.11 | 120.44 | 97.91 |
Levered Free Cash Flow | 87.32 | 783.8 | 73.93 | 132.07 | 59.29 |
Unlevered Free Cash Flow | 103.94 | 802.19 | 83.46 | 137.75 | 64.65 |
Change in Working Capital | -36.67 | 15.1 | -125.88 | -109.51 | 51.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.